# GalviVault Day 9 — Critical-Path Implementation Report

Status: **DAY 9 STOP — remote QA deployment/Human E2E unavailable from this runtime**

## D9-EV-01 — Baseline fingerprint

- Repository: `mrgalvipro/galvitriage`
- Active branch: `qa-revamped-galvicare-0-5`
- Starting SHA: `d498f42a128c5d6e8c6639850184f674cfeca1f6`
- Day 8 release-evidence commit: `51bf10ab2782d147b13d2e7481b949d9e1d36232`
- External Product Owner attestation establishes the starting SHA as the approved QA HEAD.
- The environment's outbound CONNECT tunnel returns HTTP 403. No further fetch, pull, PR, or remote promotion is claimed.
- Local ancestry passed. The only Day 8-to-starting-SHA change is the Day 9 Builder guide.

## D9-EV-02 — Minimum diff / GalviCare isolation

The implementation adds the historical-founder domain projection/importer, its protected operator integration, a synthetic fixture, a redacted dry-run, focused tests, and this report. It minimally changes Day 2 session continuity to resolve a returning founder's exact existing venture name. Public screens, payment, Stripe, HubSpot, GA4, Clarity, Calendly, Production entry, readiness/stabilization workflows, and applied migrations were not modified.

## D9-EV-03 — Secure identity input

`.local/` is ignored. The committed manifest is synthetic and uses the reserved `.invalid` domain. Dry-run output replaces email and narrative with `[REDACTED]`.

## D9-EV-04 — Schema/migration decision

**Zero migration.** Existing `gv1_` canonical tables represent founder, venture, role, BMR, historical session, accepted evidence, evidence-linked observation, import reconciliation, journey event, and audit state. The released unique BMR-per-venture index remains authoritative.

## D9-EV-05 — Day 9 automated tests

`npm run day9:gate`: **9 pass / 0 fail / 0 skipped**. The in-memory D1 integration covers synthetic import, replay, changed-fingerprint rejection, evidence lineage, no care pollution, FHR, internal intelligence authorization, returning same-venture continuity, new-venture isolation, and public-payload exclusions.

`npm run day9:import:dry-run -- --input data/day9/fhr-identity-manifest.example.json`: **PASS**; one ready row, one expected evidence item, six expected historical observations, valid checksum, no mutation, redacted output.

## D9-EV-06 — Day 1–Day 8 regression

Post-change `npm run day8:gate`: **PASS**. The focused Day 8 suite returned **34 pass / 0 fail / 0 skipped** and its inherited stabilization suite returned **143 pass / 0 fail / 0 skipped**.

## D9-EV-07 — Day 8 clinician regression

Day 8 syntax and workspace tests passed within `npm run day8:gate`. The chart projection retains protected operator routing and degrades safely if optional historical projection composition fails.

## D9-EV-08 — Public GalviCare regression

Local inherited public GalviCare contracts passed within the 143-test stabilization suite. The deployed QA smoke command could not reach `https://galvicare-0-5-qa.mrgalvipro.workers.dev/` because the environment CONNECT tunnel returned HTTP 403. This is an environment limitation; deployed HTTP 200 is not claimed for this candidate.

## D9-EV-09 — Synthetic import reconciliation

Local in-memory D1 proof imported one synthetic founder, venture, role, BMR, historical session, accepted artifact evidence, and six evidence-linked observations. Exact replay returned the same canonical IDs without duplicate records. Batch reconciliation proved `processed_count = imported_count + skipped_count + error_count`.

## D9-EV-10 — Human E2E

**Not executed against QA.** Local Worker/D1 integration proves the automated synthetic critical path, but it is not represented as deployed Human E2E. No manual repair was performed.

## D9-EV-11 — D1 assertions

Local in-memory D1 assertions passed: one BMR for the synthetic venture; one historical session on the correct BMR; every historical observation linked to evidence on that BMR; zero findings, recommendations, treatment plans, or outcomes created by import; reconciled batch counts; exact replay stability; and separate BMR for a genuinely new venture.

## D9-EV-12 — Security negatives

FHR, import, and Founder Intelligence paths exist only below the authenticated `/api/v1/operator/` namespace. Intelligence composition rejects a public actor. The public continuity response contains neither historical FHR nor Founder Intelligence Context, and client-supplied privileged canonical IDs remain rejected by the inherited Day 2 boundary.

## D9-EV-13 — Aidan reference proof

No Aidan canonical founder, venture, or BMR is created. The pure governed reference path returns only a `proposed` historical pattern candidate shape, an empty source-BMR list, and excludes synthetic sections matching Harry/Duplex/Microbeads/AMR/hospital/healthcare-regulatory contamination. The real source artifact was unavailable; candidate persistence is deferred rather than fabricated.

## D9-EV-14 — Production reconciliation

**Not executed.** Real identity/source inputs, production authorization, approved artifacts, QA deployment, and QA Human E2E were unavailable. Production backfill remains execution-deferred.

## D9-EV-15 — Rollback/deactivation

Rollback is application-only: redeploy the known-good Day 8 candidate and omit calls to the optional Day 9 operator import/projection endpoints. No schema rollback is needed. Valid canonical history must remain intact; corrections use versioning/reconciliation, never direct deletion or accepted-evidence mutation.

## D9-EV-16 — Residual defects

- Blocking release evidence gap: this runtime cannot deploy or access QA through its CONNECT tunnel, so deployed clinician/public smoke, QA Human E2E, and remote QA D1 assertions are unproven.
- Production source artifacts and controlled identity inputs are absent; production execution is deferred.
- Aidan real-source candidate creation is deferred.

## D9-EV-17 — GO/STOP

**DAY 9 STOP — local implementation and automated regression are green, but QA deployment, deployed synthetic Human E2E, deployed public smoke, and remote QA D1 proof are not available from this runtime.**
